https://www.selleckchem.com/pr....oducts/trastuzumab-d
PROSPERO registration number CRD42019129711.Introduction Chronic pain is a leading cause of disability and remains under-treated in nearly half of patients with cancer. The opioid crisis has highlighted an urgent public health need for effective nonpharmacological pain management. Electroacupuncture (EA) and Battlefield Acupuncture (BFA) represent nonpharmacological modalities used in clinical practice to manage pain; however, their effectiveness has not been rigorously evaluated in oncology settings. Methods We describe
Like
Comment
Share
